“Breast cancer” is an overarching term defining the general location of a group of cancer cells, but in reality, there are many different types of breast cancer. These different types are based on how the cancer cells appear under the microscope, the behavior of certain molecules such as hormonal receptors, and how invasive or aggressive the cells are. 

By determining a person’s specific type of breast cancer, doctors can personalize each patient’s treatment with a more tailored approach, resulting in better outcomes. Here we look at the most common types of breast cancer and their defining characteristics. 

Carcinomas (ductal and lobular) 

Carcinomas are cancers that start in the cells that line organs and tissues throughout the body, called epithelial cells. Most breast cancers fall under this category. There are two main types of breast carcinomas, which are then broken down further into invasive or non-invasive—more on that below. 

Ductal carcinomas 

Ductal carcinomas begin in the milk ducts of the breast and often form a lump that can be felt on a breast self-exam. The CDC estimates that 70 to 80 percent of breast cancers are invasive ductal carcinomas. 

Lobular carcinomas 

Lobular carcinomas start in the lobules, or glands that produce milk and connect to the milk ducts. These carcinomas are less likely to form a lump and more difficult to see on a mammogram. This type of carcinoma is more likely to form in both breasts (which is known as “bilateral breast cancer”) than ductal carcinomas. About 10 percent of breast cancers are invasive lobular carcinomas.

Three generations of women

Get the facts on breast cancer

It’s important to know if you are at a higher risk of being diagnosed with breast cancer, based on genetics or lifestyle. While the best way to stay informed is by speaking to your doctor, this quiz provides some basic facts about breast cancer.

Invasive or non-invasive breast cancer 

Defining a cancer as invasive or non-invasive indicates whether the cancer cells have spread from the original cells into other parts of the breast tissue. Non-invasive cancer is also called “in situ” cancer. 

Ductal carcinoma in situ 

This type of breast cancer is non-invasive and is sometimes called stage 0 breast cancer. These cancer cells remain in the milk ducts and don’t spread into the breast tissue. 

Lobular carcinoma in situ 

Technically, lobular carcinoma, or non-invasive lobular carcinoma, is not considered a true breast cancer. These cells are abnormal but benign. 

Hormonal and protein maker subtypes 

Most breast cancers have hormone receptors, meaning they can use estrogen and progesterone, two hormones in our bodies, as fuel to grow and multiply. 

Estrogen and progesterone receptor positive 

Estrogen receptor positive (ER positive) breast cancer uses estrogen to grow. Hormone therapy or endocrine therapy can help treat this cancer by blocking the growth of cancer cells. 

Progesterone receptor positive (PR positive) breast cancer uses progesterone. This type of cancer is also treated by endocrine therapy. Hormone receptor negative (HR negative) cancer does not use any hormones to grow the cancer. For these types of cancers, hormone or endocrine therapy is not suitable. 

Human epidermal growth factor (HER2) protein 

Human epidermal growth factor (HER2) proteins are used in normal cell growth. Around 15 percent of breast cancer overexpresses the HER2 protein, which then helps them spread faster throughout the body. Fortunately, very effective targeted therapy can be used to counteract the HER2 expression (such as trastuzumab and pertuzumab). 

Triple-negative breast cancer 

This type of breast cancer does not have estrogen or progesterone receptors and it does not create more HER2 proteins. About 15 percent of all breast cancers are triple-negative and unfortunately, this type is difficult to treat. 

Other types of breast cancers 

There are a few other types of breast cancers that are much less common. These include: 

  • Inflammatory breast cancer—accounts for one to five percent of all breast cancers, and is an aggressive type of cancer that can cause the breast to look red, swollen, and inflamed. 
  • Paget disease of the breast—cancer cells are found in the skin of the nipple and areola, and most people diagnosed with Paget disease of the breast have one or more tumors in the same breast; one to four percent of all breast cancer cases involve Paget disease. 
  • Phyllodes tumor—very rare cancer (fewer than one percent) in which the cancer cells begin in the connective tissue of the breast, called the stroma. 
  • Male breast cancer—fewer than one percent of breast cancer cases are diagnosed in men, and most of these are invasive ductal carcinomas. 

How are cancer types determined? 

Mammograms can start the process—if cancer is detected early enough, a radiologist can see where the cancer cells are. The earlier breast cancer is caught, the more significant chances of curing it. Breast cancer screening with mammograms can save lives! 

Once abnormal cells are noticed on a mammogram or other imaging test, a biopsy is taken from the area of the breast containing cancer lesions. A pathologist uses a microscope to view the cancer cells and get a better picture of all the different factors that go into typing and subtyping. 

Genetics can but don’t necessarily help with determining a cancer type—not all cancers have genetic components and it’s possible for two people in direct relation to have different types of breast cancer. However, genetics can help determine the risk of developing breast cancer and can help on the selection of the best treatment. 

Personalized treatment for all breast cancer patients 

Once the cancer’s type is known, our multidisciplinary team of cancer care experts at the Breast Cancer Center can get to work on tailoring treatment for each patient. At Brown University Health Cancer Institute, we deliver world-class cancer care to our patients and community, with convenient mammography locations, cancer education and screening events, and if needed, state-of-the-art breast cancer treatment. Our ongoing commitment to researching and treating breast cancer is supported with clinical trials that deliver specialized treatments to our patients and help to improve outcomes.

Headshot of Alvaro Alvarec Soto MD

Alvaro Alvarez Soto, MD

Dr. Alvaro Alvarez Soto is an oncologist at the Brown University Health Cancer Institute